161 related articles for article (PubMed ID: 35743514)
1. Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation.
de Vries VA; Pals J; Poelman HJ; Rostamzad P; Wolfs RCW; Ramdas WD
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743514
[TBL] [Abstract][Full Text] [Related]
2. Micropulse transscleral cyclophotocoagulation in a Taiwanese population: 2-year clinical outcomes and prognostic factors.
Chen HS; Yeh PH; Yeh CT; Su WW; Lee YS; Chuang LH; Shen SC; Wu WC
Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1265-1273. PubMed ID: 34694457
[TBL] [Abstract][Full Text] [Related]
3. Transscleral vs endoscopic cyclophotocoagulation: safety and efficacy when combined with phacoemulsification.
Nirappel A; Klug E; Neeson C; Chachanidze M; El Helwe H; Hall N; Chang TC; Shen LQ; Solá-Del Valle D
BMC Ophthalmol; 2023 Mar; 23(1):129. PubMed ID: 36997879
[TBL] [Abstract][Full Text] [Related]
4. MicroPulse Transscleral Laser Therapy Demonstrates Similar Efficacy with a Superior and More Favorable Safety Profile Compared to Continuous-Wave Transscleral Cyclophotocoagulation.
Bernardi E; Töteberg-Harms M
J Ophthalmol; 2022; 2022():8566044. PubMed ID: 35178250
[TBL] [Abstract][Full Text] [Related]
5. Micropulse vs. continuous wave transscleral cyclophotocoagulation in neovascular glaucoma.
Zemba M; Dumitrescu OM; Vaida F; Dimirache EA; Pistolea I; Stamate AC; Burcea M; Branisteanu DC; Balta F; Barac IR
Exp Ther Med; 2022 Apr; 23(4):278. PubMed ID: 35317447
[TBL] [Abstract][Full Text] [Related]
6. Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes.
de Crom RMPC; Slangen CGMM; Kujovic-Aleksov S; Webers CAB; Berendschot TTJM; Beckers HJM
J Glaucoma; 2020 Sep; 29(9):794-798. PubMed ID: 32459690
[TBL] [Abstract][Full Text] [Related]
7. Medium-term Outcomes of Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma.
Valle IT; Bazarra SP; Taboas MF; Cid SR; Diaz MDA
J Curr Glaucoma Pract; 2022; 16(2):91-95. PubMed ID: 36128078
[TBL] [Abstract][Full Text] [Related]
8. Morphological Changes and Potential Mechanisms of Intraocular Pressure Reduction after Micropulse Transscleral Cyclophotocoagulation in Rabbits.
Tsujisawa T; Ishikawa H; Uga S; Asakawa K; Kono Y; Mashimo K; Shoji N
Ophthalmic Res; 2022; 65(5):595-602. PubMed ID: 32739916
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of a combination of augmented MicroPulse and limited Continuous Wave Cyclophotocoagulation in patients with refractory glaucoma.
Gupta S; Chang EK; Chachanidze M; Hall N; Neeson C; Klug E; Chang TC; Solá-Del Valle DA
Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1583-1592. PubMed ID: 34694455
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes of micropulse transscleral cyclophotocoagulation as a primary versus additional therapy in eyes with uncontrolled glaucoma.
Rajendrababu S; Senthilkumar VA; Tara TD; Uduman MS; Aila LA; Shukla AG
Indian J Ophthalmol; 2023 Jan; 71(1):140-145. PubMed ID: 36588224
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Micropulse Transscleral Cyclophotocoagulation in Eyes With Good Central Vision.
Varikuti VNV; Shah P; Rai O; Chaves AC; Miranda A; Lim BA; Dorairaj SK; Sieminski SF
J Glaucoma; 2019 Oct; 28(10):901-905. PubMed ID: 31385915
[TBL] [Abstract][Full Text] [Related]
12. Micropulse Transscleral Cyclophotocoagulation as Primary Surgical Treatment for Primary Open Angle Glaucoma in Taiwan during the COVID-19 Pandemic.
Chang HL; Chao SC; Lee MT; Lin HY
Healthcare (Basel); 2021 Nov; 9(11):. PubMed ID: 34828609
[TBL] [Abstract][Full Text] [Related]
13. Real-life experience of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in advanced and uncontrolled cases of several glaucoma types: a multicentric retrospective study.
Laruelle G; Pourjavan S; Janssens X; Marinescu-George C; Boustani G
Int Ophthalmol; 2021 Oct; 41(10):3341-3348. PubMed ID: 34052964
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Micropulse Laser Cyclophotocoagulation Therapy in Primary Angle Closure Glaucoma.
Chauhan D; Midha N; Mahalingam K; Angmo D; Sihota R; Gupta S; Chawla R; Dada T
J Glaucoma; 2023 Dec; 32(12):1011-1017. PubMed ID: 38200659
[TBL] [Abstract][Full Text] [Related]
15. First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma.
Bernardi E; Töteberg-Harms M
Int Ophthalmol; 2022 Aug; 42(8):2363-2369. PubMed ID: 35113312
[TBL] [Abstract][Full Text] [Related]
16. Micropulse trans-scleral diode laser cyclophotocoagulation in refractory glaucoma: an initial experience in Indian eyes.
Ariga M; Nivean ; Nivean PD; Madanagopalan VG; Mohan S
Int Ophthalmol; 2021 Aug; 41(8):2639-2645. PubMed ID: 33550537
[TBL] [Abstract][Full Text] [Related]
17. Transscleral cyclophotocoagulation with MicroPulse
Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Papadonta SA; Armeni EZ; Kohlhaas M
Int Ophthalmol; 2021 Apr; 41(4):1271-1282. PubMed ID: 33392944
[TBL] [Abstract][Full Text] [Related]
18. Success rate in micropulse diode laser treatment with regard to lens status, refractive errors, and glaucoma subtypes.
Zanutigh V; Perrone LD; Gómez-Caride G; Perrone F; Valvecchia G; Logioco C
Int Ophthalmol; 2023 Jul; 43(7):2407-2417. PubMed ID: 36715958
[TBL] [Abstract][Full Text] [Related]
19. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma.
Tan AM; Chockalingam M; Aquino MC; Lim ZI; See JL; Chew PT
Clin Exp Ophthalmol; 2010 Apr; 38(3):266-72. PubMed ID: 20447122
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of initial and repeat micro-pulse transscleral cyclophotocoagulation in adult glaucoma patients.
Hooshmand S; Voss J; Hirabayashi M; McDaniel L; An J
Ther Adv Ophthalmol; 2022; 14():25158414211064433. PubMed ID: 35187401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
